Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.

Cortese, Rosa; Battaglini, Marco; Prados, Ferran; Gentile, Giordano; Luchetti, Ludovico; Bianchi, Alessia; Haider, Lukas; Jacob, Anu et al. · Ann Neurol · 2024

retrospective_cohort · Level III

Where this comes from

Abstract

To evaluate: (1) the distribution of gray matter (GM) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), and relapsing-remitting multiple sclerosis (RRMS); and (2) the relationship between GM volumes and white matter lesions in various brain regions within each disease. A retrospective, multicenter analysis of magnetic resonance imaging data included patients with MOGAD/AQP4+NMOSD/RRMS in non-acute disease stage. Voxel-wise analyses and general linear models were used to evaluate the relevance of regional GM atrophy. For significant results (p < 0.05), volumes of atrophic areas are reported. We studied 135 MOGAD patients, 135 AQP4+NMOSD, 175 RRMS, and 144 healthy controls (HC). Compared with HC, MOGAD showed lower GM volumes in the temporal lobes, deep GM, insula, and cingulate cortex (75.79 cm<sup>3</sup>); AQP4+NMOSD in the occipital cortex (32.83 cm<sup>3</sup>); and RRMS diffusely in the GM (260.61 cm<sup>3</sup>). MOGAD showed more pronounced temporal cortex atrophy than RRMS (6.71 cm<sup>3</sup>), whereas AQP4+NMOSD displayed greater occipital cortex atrophy than RRMS (19.82 cm<sup>3</sup>). RRMS demonstrated more pronounced deep GM atrophy in comparison with MOGAD (27.90 cm<sup>3</sup>) and AQP4+NMOSD (47.04 cm<sup>3</sup>). In MOGAD, higher periventricular and cortical/juxtacortical lesions were linked to reduced temporal cortex, deep GM, and insula volumes. In RRMS, the diffuse GM atrophy was associated with lesions in all locations. AQP4+NMOSD showed no lesion/GM volume correlation. GM atrophy is more widespread in RRMS compared with the other two conditions. MOGAD primarily affects the temporal cortex, whereas AQP4+NMOSD mainly involves the occipital cortex. In MOGAD and RRMS, lesion-related tract degeneration is associated with atrophy, but this link is absent in AQP4+NMOSD. ANN NEUROL 2024;96:276-288.

Medical subject headings